KOPRAN logo

Kopran LTD

KOPRAN·NSE·
216.65 -0.93 (-0.43%)
Market Cap1045.53 Cr
PE Ratio40.65
Volume1,60,776
Day High - Low220.40 - 214.04
52W High-Low235.07 - 107.00
DocStoX Score
3.2/10
Poor
Fair Value
Sign in to see
ROE
4.91%
Weak
P/E
40.65x
Expensive
Debt / Equity
0.10
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day214.04
220.40
52W107.00
235.07
DocStoX take

Supported by momentum (7.5) and risk (6.7), but held back by valuation (0.7). Momentum looks strong at 7.5, but that is offset by valuation at 0.7 and growth at 1.1 and quality at 2.7. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
3.2
/10
Poor
Quality
Weak
ROE 4.9%
Valuation
Expensive
P/E 40.6×
Growth
Flat
Revenue +6.7% 5Y CAGR
Risk
Moderate
D/E 0.10
Momentum
Strong
86% of 52-week range

At a glance

Market Cap
₹1,046 Cr
52W High / Low
₹235 / ₹107
Dividend Yield
1.56%
Promoter Holding
44.42%
EPS (TTM)
₹5.33
Book Value
₹110.00

Key highlights

  • Low leverage — D/E 0.10
  • Profitable in all of the last 5 years
  • Profit shrinking 16% a year
  • Valuation is weak (0.7/10)
2 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

KOPRAN LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.